From eNewsletter 6/9/2021
DID YOU KNOW that the FDA recently sent warning letters to several companies instructing them not to market dietary supplements containing N-acetyl-L-cysteine (NAC)? This prompted several major distribution outlets, including Amazon, to remove it from their websites. There has been much confusion over the FDA's stance, so we will clear it up for you. NAC has been used safely as a dietary supplement for decades. It is a precursor to glutathione. The FDA has not removed it from the market, as they do not have the authority to do so. Simply, they can warn retailers not to market NAC as a dietary supplement, meaning retailers can carry it, but not promote it or have it listed on their website. The Council for Responsible Nutrition is already petitioning the FDA's stance and has 180 days to respond to the petition. NAC has not been pulled from the market and is available. It is just more difficult to procure it because many distribution outlets are not listing it on their websites. So you may have to call, email, text, or chat with the company you procure it from.
New Products Pure Encapsulations debuted an allergy complex called Hist Reset and three new gummy supplements: Vitamin C, Vitamin D, and Zinc!
Text Us To better serve your needs, we now have the ability to accept text messages. Simply type in (847) 498-3422 and text away!
UPDATE - COVID-19 Vaccine Information We updated this document Monday, June 7th.
Virus Prevention And Treatment Vaccines will minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is not going away, as evidenced by its ever-mutating variants. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others.We highly recommend continuing your immune support. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.
COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.
Post-COVID Syndrome The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome Action Plan for purchase, or free to paid members here, can bring measurable improvement.
Steve and Bonnie: If you wonder why we want you to take an antihistamine prior to getting the COVID-19 vaccine, look no further than a new study from Medrxiv. COVID-19 infection, and the vaccine on a much more minor scale, activate mast cells, which create allergic inflammation. Excessive mast cell production can lead to severe COVID-19 infection. It can also lead to allergic reactions and other immediate side effects to the vaccine.
Please share our protocol with anyone you know so that they will be protected from potential excess mast cell production.
Origin of the Pandemic No Slam Dunk
It is imperative that we find the origin of SARS-CoV-2 so that we may take steps to assure nothing like this pandemic ever happens again. While nothing is definitive, there are clues that SARS-CoV-2 may have been manipulated by scientists. Aside from the White House calling on all intelligence agencies to pool their resources to find the cause, almost 15 months ago, two Chinese researchers wrote a paper concluding that the virus “probably originated from a laboratory in Wuhan.” Alina Chan, a molecular biologist affiliated with Harvard and M.I.T., made similar arguments. Many more scientists have come forward saying it is possible, so hopefully we can get to the truth sooner than later.
Supplements and COVID-19 Incidence, Severity
A study from the May issue of Nutrients states the absence of vitamin and mineral deficiency significantly reduced COVID-19 incidence and clinical deterioration in hospitalized patients. Usage of micronutrients as prophylaxis and complementary supplements in therapeutic management of COVID-19 patients is a promising and cost-effective approach.
Of the 32 million Americans who have gotten COVID infections, 85% suffered a partial or full loss of their sense of smell. Much of this is related to zinc deficiency.
Immunity Answers Are Still Fleeting
Over the last few months, many studies have been published on the length of immunity after getting COVID-19 infection. One study in Nature suggests that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.
Another study from JAMA Internal Medicine found reinfections are rare events and patients who have recovered from COVID-19 have a lower risk of reinfection. Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported in recent vaccine studies. However, the observation ended before SARS-CoV-2 variants began to spread, and it is unknown how well natural immunity to the wild-type virus will protect against variants.
We are still unsure and until there is a titer test, we really have no definitive answer.
More on Myocarditis, Heart Side Effects From COVID-19 Infection, Vaccines
Last week, we mentioned a study from Circulation that found only four percent of athletes showed heart abnormalities and all were able to resume athletic activities after recovery. More research has come out since then.
College athletes who have recently recovered from COVID-19 infection show cardiac abnormalities on electrocardiography. In a small study of ECGs on National Collegiate Athletic Association Division II athletes, those who had been infected with COVID-19 had a prolonged PR interval compared with matched athletes who had not been infected. The study was presented at the 2021 Virtual American College of Sports Medicine Annual Meeting & World Congresses.
In another study of 1597 competitive collegiate athletes undergoing comprehensive cardiovascular testing in the United States, the prevalence of clinical myocarditis based on a symptom-based screening strategy was only 0.31%. But screening with cardiac MRI increased the prevalence of clinical and subclinical myocarditis by a factor of 7.4, to 2.3%, the authors report in JAMA Cardiology.